Drug
Ceftobiprole Medocaril
Ceftobiprole Medocaril: highest development phase Phase 3, developed by ISTx, LLC. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- ISTx, LLC
Trials
| Drug | Phase | Indication |
|---|---|---|
| Ceftobiprole medocaril sodium NCT07929493 | Phase 3 | Staphylococcus Aureus Bacteremia |
Latest
No recent events.
Follow Ceftobiprole Medocaril on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.